HOME >> BIOLOGY >> NEWS
Public health measures can contain SARS, two modeling studies suggest

The SARS virus is contagious enough to cause a very large epidemic if left unchecked, but could nonetheless be controlled with rigorous public health measures, two research teams report. These results are being released today by the journal Science, published by the American Association for the Advancement of Science (AAAS).

Both teams used data about recent SARS cases to make projections about how the epidemic will proceed under various circumstances. They found that the SARS virus seems to be moderately rather than highly contagious and could thus be controlled by careful interventions that, for example, reduced contacts by infected people, or helped them receive treatment more quickly.

In one of the studies, U.S. and Canadian researchers used their model to investigate how effective different control measures could be. The possibilities they considered -- including early case detection, reducing each patient's infectiousness, and quarantine -- could all have major impacts on the epidemic, especially when used in combination, the scientists found.

The second study, by U.K. and Hong Kong researchers, focused specifically on Hong Kong, and found that public health efforts currently seem to have brought the epidemic under control. Reduced contact rates in both hospitals and the community were primarily responsible for this success, with rapid hospitalization playing a less important role, according to study.

"It's difficult to predict, this early on, how an epidemic will spread, especially when it's caused by a previously unknown virus. Modeling studies like these -- while preliminary -- suggest that we are headed in the right direction to stop the epidemic," said Caroline Ash, a microbiologist and Science editor working in Cambridge, U.K.

"Modeling studies can give us important information about the quantitative aspects of the epidemic -- how many people are infected, on average by each case; how many people would pot
'"/>

Contact: Kathy Wren
kwren@aaas.org
617-524-6289
American Association for the Advancement of Science
23-May-2003


Page: 1 2 3

Related biology news :

1. Reporters from Science Magazine to receive ASM Public Communications Award
2. NIEHS/NTP Director Dr. Kenneth Olden receives Society of Toxicologys Public Communications Award
3. GM nation? Public debate: a valuable experiment
4. John Allen Paulos receives prestigious AAAS Award for Public Understanding of S&T
5. Public Library of Science launches PLoS Biology
6. Dr. Gonsalves will receive ASPB Leadership in Science Public Service Award
7. AACR forum to discuss stem cells and cancer research: Public policy issues
8. Public Library of Science acts to increase public access to scientific research
9. Public knows no more about genetics than in 1990, U-M study shows
10. Natural Science and Public Health: Prescription for a Better Environment
11. School of Public Health awarded $30 million to develop and introduce pneumococcal vaccine

Post Your Comments:
(Date:3/24/2015)... March 24, 2015   Crossmatch ™, a ... announced that its U.are.U ® 4500 Fingerprint ... Goorin Bros . to achieve PCI compliance for ... access to the POS terminal, protecting the retailer ... data breaches. With one-third of ...
(Date:3/23/2015)... Mar. 23, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... the growing mobile commerce market, announces its biometric payment technology, ... on CNBC television starting March 30 th . ... in New York markets. ... are excited about our new ad campaign following the recent ...
(Date:3/20/2015)... , Mar. 19, 2015 Research and Markets ... "Iris Biometrics - Global Strategic Business Report" report ... markets for Iris Biometrics in US$ Thousands. The report provides ... , Japan , Europe ... , and Latin America . ...
Breaking Biology News(10 mins):Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5
(Date:4/16/2015)... Morton Grove, IL (PRWEB) April 16, 2015 ... the American Association for Cancer Research (AACR) ... at the Pennsylvania Convention Center, starting Saturday, April 18, ... The AACR holds claim to title of the oldest ... several journals, provides fellowships and grants, and partners with ...
(Date:4/16/2015)... The Council for Agricultural Science and ... CAST Communication Award goes to Dr. Channapatna Prakash, ... Alabama. Award nominees must demonstrate an ability to ... use of television, radio, or other social media. ... specialist in the field of plant genetics and ...
(Date:4/16/2015)... Md. , April 16, 2015  RegeneRx ... today announced its U.S. joint venture with G-treeBNT ... a phase 3 clinical trial for the orphan ... confirmatory trial for dry eye syndrome (DES) in ... preservative-free eye drops, RGN-259/GBT201, this year.  Each of ...
(Date:4/16/2015)... A new infographic compiles useful information ... institutions to learn how Appleā€™s new framework can change ... is ideal since Apple made Research Kit ... open-source framework for developing medical research apps that Apple ... researchers to collect secure clinical data and communicate via ...
Breaking Biology Technology:Regis Technologies Joins American Association for Cancer Research Annual Meeting 2The 2015 Borlaug CAST Communication Award Goes to Channapatna Prakash 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5Infographic Illustrates Potential for Research Kit to Impact Clinical Research 2Infographic Illustrates Potential for Research Kit to Impact Clinical Research 3
Cached News: